ReviewInternational journal of molecular sciences2025

JAK2 46/1 (GGCC) Haplotype in Oncogenesis, as Risk Stratifier, and Indicator for Drug Resistance in Myeloproliferative Neoplasms.

Michela Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.